ZofiaKozakMD

PubMed

• New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.
  Aaronson, S., Kozak, Z.> ;Med. 2024 Mar 8
• Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.
  Thrul, J., Garcia-Romeu, A., Yaden, D., Kozak, Z., Carducci, M.> ;Cancer. 2024 Apr 1
• 5 citations
  Assessing potential of psilocybin for depressive disorders.
  Zofia Kozak, Matthew W Johnson, Scott T Aaronson> ;Expert Opinion on Investigational Drugs. 2023 Nov 6
• Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs.
  Zofia Kozak, Glenna J Urquhart, Saba Rouhani, Sean T Allen, Ju N Park, Susan G Sherman> ;The American Journal on Addictions. 2024 Jan 1
• 2 citations
  Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment.
  Zofia Kozak, Daniel Ciccarone, Johannes Thrul, Thomas O Cole, Alexander L Pappas, Aaron D Greenblatt, Christopher Welsh, Mark Yoon, Donald Gann Jr, E Erin Artigiani, E...> ;Harm Reduction Journal. 2023 Feb 14
• Patients With Schizophrenia-Spectrum Disorders as Vulnerable Populations in an Age of Misinformation: A Case Report of Ivermectin-Related Liver Failure.
  Nicholas Fioravante, Zofia Kozak, David Glovinsky> ;Journal of the Academy of Consultation-Liaison Psychiatry. 2022 Dec 15
• 12 citations
  Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
  Annabelle M. Belcher, Thomas O. Cole, Aaron D. Greenblatt, Stephen W. Hoag, David H. Epstein, Michael Wagner, Amy S. Billing, Ebonie Massey, Kristen R. Hamilton, Zofia...> ;BMJ Open. 2019 Jun 1
• Join now to see all

Journal Articles

• Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer  
  Johannes Thrul PhD, Zofia Kozak MD, Michael A. Carducci MD, Albert Garcia-Romeu PhD, David B. Yaden PhD, Cancer, 12/18/2023